New special tax on Hungarian drug distributors jeopardizing supply

The continued depreciation of the forint, the pandemic and then the war in Ukraine have seriously endangered secure access to modern medical treatment, which is now exacerbated by the disproportionate and high increase in special taxes which can lead to unintended consequences, according to the Hungarian pharmaceutical trade group Association of Innovative Pharmaceutical Industrialists (AIPM).

As they have done each time in the past when the need arose, innovative…

This article is accessible to registered users, to continue reading, please register for free. A free trial will give you access to exclusive features, interviews, summaries and commentary from the sharpest minds in the pharma and biotech space for one week. If you are already a registered user, please login. If your trial period is over, you can register here.

Try before you buy

• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analysis and commentary from our global network of life science journalists.
• Receive The Pharma Letter daily newsletter, free forever.

Become a subscriber

• Unfettered access to top pharmaceutical and biotechnology industry news, commentary and analysis.
• Updates on clinical trials, conferences, mergers and acquisitions, licensing, financing, regulatory, patent and legal, executive appointments, business strategy and financial results.
• Daily roundup of key events in pharma and biotechnology.
• In-depth monthly briefings on board appointments and M&A news.
• Choose between an economical annual plan or a flexible monthly subscription.

Laura T. Thrasher